Boston Scientific Amends 2023 Annual Report

Ticker: BSX · Form: 10-K/A · Filed: 2024-02-21T00:00:00.000Z

Sentiment: neutral

Topics: amendment, annual-report, SEC-filing

TL;DR

**BSX just filed an amended 10-K for 2023, so keep an eye out for what changed!**

AI Summary

BOSTON SCIENTIFIC CORP (NYSE: BSX) filed a Form 10-K/A (Amendment No. 1) on February 21, 2024, for the fiscal year ended December 31, 2023. This amendment updates their annual report originally filed under the Securities Exchange Act of 1934. The company, incorporated in Delaware with IRS Employer Identification No. 04-2695240, is headquartered at 300 Boston Scientific Way, Marlborough, Massachusetts.

Why It Matters

This amendment indicates a correction or update to previously reported financial or operational information, which could impact investor perception and valuation of Boston Scientific.

Risk Assessment

Risk Level: medium — An amended 10-K can signal corrections to previously reported data, which introduces uncertainty and potential for revised financial outlooks.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of this 10-K/A filing by BOSTON SCIENTIFIC CORP?

This 10-K/A (Amendment No. 1) is an amendment to the Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2023.

When was this amended report filed with the SEC?

The amended report was filed as of February 21, 2024.

What is the fiscal year-end covered by this filing?

The fiscal year ended December 31, 2023, is covered by this filing.

Where is BOSTON SCIENTIFIC CORPORATION's business address?

BOSTON SCIENTIFIC CORPORATION's business address is 300 Boston Scientific Way, Marlborough, Massachusetts 01752-1234.

What is BOSTON SCIENTIFIC CORP's Central Index Key (CIK)?

BOSTON SCIENTIFIC CORP's Central Index Key (CIK) is 0000885725.

From the Filing

0000885725-24-000020.txt : 20240221 0000885725-24-000020.hdr.sgml : 20240221 20240221164718 ACCESSION NUMBER: 0000885725-24-000020 CONFORMED SUBMISSION TYPE: 10-K/A PUBLIC DOCUMENT COUNT: 19 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240221 DATE AS OF CHANGE: 20240221 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 24660506 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 10-K/A 1 bsx-20231231.htm 10-K/A bsx-20231231 0000885725 2023 FY false 0000885725 2023-01-01 2023-12-31 0000885725 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0000885725 bsx:SeniorNotedue2027Member 2023-01-01 2023-12-31 0000885725 2023-06-30 iso4217:USD iso4217:USD xbrli:shares 0000885725 2024-01-31 xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☑   ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934, or For the fiscal year ended December 31 , 2023 ☐   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No.  1-11083 BOSTON SCIENTIFIC CORPORATION (Exact name of registrant as specified in its charter) Delaware 04-2695240 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)      300 Boston Scientific Way , Marlborough , Massachusetts                      01752-1234         (Address of Principal Executive Offices)                         (Zip Code) 508   683-4000 (Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value BSX New York Stock Exchange 0.625% Senior Notes due 2027 BSX27 New York Stock Exchange Securities registered pursuant to Section 12(g) of the Act: NONE Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes : ☑ No ☐ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes: ☐ No ☑ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes : ☑ No ☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorted period that the registrant was required to submit such files). Yes : ☑ No ☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,”

View on Read The Filing